← SynDRA
cefetamet pivoxil
SynDRA canonical compound SYN0041687 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | bacterial cell wall synthesis inhibitor |
|---|
| Indication | gram-positive bacterial infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA1
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4A
- PDE4D
- PGR
- PTGS1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR1A
- HRH3
- HRH2
- CHRM2
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB2
- AR
- CHRM1
- CHRM3
- HRH1
- CNR1
- DRD1
- DRD2
- DRD3
- ESR1
- F2
- HDAC6
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01D · OTHER BETA-LACTAM ANTIBACTERIALS
Cross-references
Synonyms
- ceftamet pivoxil
- cefetamet pivoxil hydrochloride
- cefetamet pivoxil HCl
- Cefetamet pivoxil hcl
- Globocef (TN)
- Cefetamet pivoxyl
- Cefetamet pivaloyloxymethyl ester
- F6XA85N260
- RefChem:918186
- DTXCID0065272
- C20H25N5O7S2
- UNII-F6XA85N260
- CEFATAMET PIVOXIL
- NCGC00181788-01
- SCHEMBL74256
- CEFATAMET PIVOXIL [MI]
- DASYMCLQENWCJG-XUKDPADISA-
- CHEBI:135812
- CEFETAMET PIVOXIL [WHO-DD]
- HY-B1894
- MSK12004
- FC44060
- Cefditoren impurity 3, Cefetamet Pivoxil
- DA-62182
- CS-0013956
- NS00011578
- BRD-K21372554-001-01-1
- BRD-K21372554-003-01-7
- BRD-K21372554-003-02-5
- Cefetamet Pivoxil Hydrochloride
- Globocef
- 2YE9732GFU
- Ro-15-8075
- RefChem:918187
- Cefyl
- MFCD00864931
- Cefetamet pivoxil (hydrochloride)
- Ceftamet Pivoxil
Look up cefetamet pivoxil in the interactive SynDRA portal →